Sign in

CIK 0001754068

  • Non-accelerated filer
  • Smaller reporting company

Kalaris Therapeutics, Inc.

Sign in to watch
Ticker
KLRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831971007
Phone
+1 650-249-2727
Business address
400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
Former names
Allovir, Inc., ViraCyte, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 25 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-09-17 Melian Agustin Chief Medical Officer Sale −2,950 $24.01 $71K 475,968
2021-09-15 Melian Agustin Chief Medical Officer Sale −800 $24.03 $19K 478,918
2021-09-02 VAN BEEK JEROEN B Chief Commercial Officer Sale −513 $19.86 $10K 441,095
2021-08-17 VAN BEEK JEROEN B Chief Commercial Officer Sale −15,205 $17.82 $271K 441,608
2021-07-02 Melian Agustin Chief Medical Officer Sale −18,586 $19.99 $372K 479,718
2021-06-03 VAN BEEK JEROEN B Chief Commercial Officer Sale −508 $22.87 $12K 456,813
2021-05-25 GADICKE ANSBERT Director Grant or award · Stock Option (Right to Buy) +22,500 22,500
2021-05-25 Hallal David Director Grant or award · Stock Option (Right to Buy) +22,500 22,500
2021-05-25 Brenner Malcolm Director Gift −818,663 0
2021-05-25 Brenner Malcolm Director Grant or award · Stock Option (Right to Buy) +22,500 22,500
2021-05-25 Wilson John Robert Director Grant or award · Stock Option (Right to Buy) +22,500 22,500
2021-05-25 Bornstein Jeffrey S Director Grant or award · Stock Option (Right to Buy) +22,500 22,500
2021-05-25 Vera Juan Director Grant or award · Stock Option (Right to Buy) +22,500 22,500
2021-05-25 Jovan-Embiricos Morana Director Grant or award · Stock Option (Right to Buy) +22,500 22,500
2021-05-18 VAN BEEK JEROEN B Chief Commercial Officer Sale −15,201 $22.80 $347K 457,321
2021-05-17 Brainard Diana Chief Executive Officer Grant or award +30,000 36,300
2021-05-17 Brainard Diana Chief Executive Officer Grant or award +170,000 206,300
2021-05-17 Brainard Diana Chief Executive Officer Grant or award · Stock Option (Right to Buy) +500,000 500,000
2021-05-10 Leen Ann M. Chief Scientific Officer Sale −150,000 $22.75 $3.4M 2,309,142
2021-04-05 Melian Agustin Chief Medical Officer Sale −18,212 $23.89 $435K 498,304

Page 18 of 27 · 527 trades